Cargando…
Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation
Tumor-derived transforming growth factor β1 (TGFβ1) generally abrogates the immunogenicity of dendritic cells (DCs) fused to whole cancer cells. We have recently revealed that ethanol-treated neoplastic cells fused to DCs exposed to 2 Toll-like receptor agonists efficiently induce cytotoxic T lympho...
Autores principales: | Koido, Shigeo, Homma, Sadamu, Okamoto, Masato, Namiki, Yoshihisa, Kan, Shin, Takakura, Kazuki, Kajihara, Mikio, Uchiyama, Kan, Hara, Eiich, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805650/ https://www.ncbi.nlm.nih.gov/pubmed/24167764 http://dx.doi.org/10.4161/onci.25375 |
Ejemplares similares
-
The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013) -
Fusions between dendritic cells and whole tumor cells as anticancer vaccines
por: Koido, Shigeo, et al.
Publicado: (2013) -
Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions
por: Koido, Shigeo, et al.
Publicado: (2013) -
Antigen-Specific Polyclonal Cytotoxic T Lymphocytes Induced by Fusions of Dendritic Cells and Tumor Cells
por: Koido, Shigeo, et al.
Publicado: (2010) -
Cancer Vaccine by Fusions of Dendritic and Cancer Cells
por: Koido, Shigeo, et al.
Publicado: (2009)